Form 4 Tracker
BIO-RAD LABORATORIES, INC.
BIO BIO.B

20 insider filings · Latest: Sep 4, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
May 28, 2026May 28 7:04 PMAlles Institute for Medical Research Corp
Proposed Sale
700$313.28$219.3K—

View →

May 11, 2026May 13 7:38 PMEva Anette EngelhardtEVP, President, CDG
Sale
550$246.54$135.6K346(D)

View →

May 11, 2026May 11 9:03 PMEVA ENGELHARDT
Proposed Sale
550$246.54$135.6K—

View →

Dec 2, 2025Dec 2 11:27 PMMICHAEL W CROWLEY
Proposed Sale
776$319.56$248.0K—

View →

Nov 18, 2025Nov 18 6:03 PMAlles Institute for Medical Research Corp
Proposed Sale
760$301.04$228.8K—

View →

Nov 6, 2025Nov 6 9:24 PMJAMES BARRY
Proposed Sale
701$306.18$214.6K—

View →

Aug 5, 2025Aug 5 8:47 PMMICHAEL W CROWLEY
Proposed Sale
1,488$275.92$410.6K—

View →

Mar 13, 2025Mar 13 9:17 PMCrowley Michael
Proposed Sale
3,000$260.00$780.0K—

View →

Mar 11, 2025Mar 11 4:36 PMAlles Institute for Medical Research Corp
Proposed Sale
410$247.66$101.5K—

View →

Nov 6, 2024Nov 6 11:26 PMLast Andrew J.
Proposed Sale
3,000$373.64$1.1M—

View →

Sep 12, 2024Sep 12 10:22 PMLast Andrew J.
Proposed Sale
1,600$321.57$514.5K—

View →

Sep 6, 2024Sep 6 8:16 PMLast Andrew J.
Proposed Sale
3,000$329.94$989.8K—

View →

Sep 4, 2024Sep 4 10:24 PMBARRY JAMES
Proposed Sale
623$330.49$205.9K—

View →

Aug 27, 2024Aug 27 4:45 PMAlles Institute for Medical Research Corp
Proposed Sale
990$311.34$308.2K—

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Sep 5, 2026Sep 9 10:42 PMRoop Kalyan LakkarajuEVP, Chief Financial Officer
Option Exercise
1,370—4,110(D)

View →

Sep 4, 2026Sep 9 10:42 PMRoop Kalyan LakkarajuEVP, Chief Financial Officer
Grant/Award
6,326—6,326(D)

View →

Sep 6, 2026Sep 9 10:42 PMNorman D SchwartzDirector, Chairman & CEO, 10% Owner
Option Exercise
3,455—6,912(D)

View →

Sep 5, 2026Sep 9 10:42 PMNorman D SchwartzDirector, Chairman & CEO, 10% Owner
Option Exercise
4,109—12,330(D)

View →

Sep 4, 2026Sep 9 10:42 PMNorman D SchwartzDirector, Chairman & CEO, 10% Owner
Grant/Award
17,251—17,251(D)

View →

Sep 1, 2026Sep 3 9:41 PMJames BarryEVP, President, LSG
Option Exercise
425—251(D)

View →

Sep 1, 2026Sep 3 9:38 PMSchwartz AllisonDirector
Option Exercise
117—75(D)

View →

Sep 1, 2026Sep 3 9:35 PMNorman D SchwartzDirector, Chairman & CEO, 10% Owner
Option Exercise
5,087—3,005(D)

View →

Jul 25, 2026Jul 28 7:05 PMEva Anette EngelhardtEVP, President, CDG
Option Exercise
246—492(D)

View →

Apr 24, 2026Apr 28 4:21 PMRoop Kalyan LakkarajuEVP, Chief Financial Officer
Option Exercise
1,078—2,156(D)

View →

Apr 24, 2026Apr 28 4:20 PMCourtney C EnloeEVP, General Counsel & Sec
Option Exercise
186—372(D)

View →

Apr 21, 2026Apr 23 7:26 PMGreg K HinckleyDirector
Option Exercise
407—0(D)

View →

Apr 21, 2026Apr 23 7:26 PMGreg K HinckleyDirector
Grant/Award
369—369(D)

View →

Apr 21, 2026Apr 23 7:25 PMMelinda Litherland PeiDirector
Grant/Award
369—369(D)

View →

Apr 21, 2026Apr 23 7:25 PMMelinda Litherland PeiDirector
Option Exercise
407—0(D)

View →

Apr 21, 2026Apr 23 7:24 PMJeffrey L EdwardsDirector
Grant/Award
369—369(D)

View →

Apr 21, 2026Apr 23 7:24 PMJeffrey L EdwardsDirector
Option Exercise
407—0(D)

View →

Apr 21, 2026Apr 23 7:23 PMArnold A PinkstonDirector
Option Exercise
407—0(D)

View →

Apr 21, 2026Apr 23 7:23 PMArnold A PinkstonDirector
Grant/Award
369—369(D)

View →

← Previous

Page 2 of 2